Potassium Chloride IV

Potassium Chloride Iv

Form: Intravenous Infusion

Strength: 2 mEq/mL, 10 mEq/5 mL, 20 mEq/10 mL

Reference Brands: Klor-Con®(US), Kalium Chlorid B. Braun®(EU)

Category: Critical Care

Potassium Chloride IV is a critical electrolyte replenishment solution used to treat or prevent hypokalemia in hospitalized patients. It is available in concentrated vials (2 mEq/mL, 10–20 mEq/10 mL) and premixed infusion bags (10–40 mEq in 100–1000 mL). Leading brands in the US include Klor-Con®, Baxter, and Hospira, while EU markets feature Kalium Chlorid by B. Braun and Fresenius. Due to its vital role in cardiac and neuromuscular function, Potassium Chloride IV is a high-priority hospital medicine. Pharma B2B platforms ensure consistent, large-scale procurement of Potassium Chloride IV solutions for ICUs, emergency departments, and critical care facilities.

Get Enquiry Back to Listing
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'

The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.

Related Products

Glucagon

Strength: 1 mg lyophilized powder for reconstitution (IM/SC/IV)

Form: Intramuscular (IM), Subcutaneous (SC), and Intravenous (IV) injection

Reference Brands: Glucagen®, Gvoke®,Baqsimi®(US); Glucagen® Hypokit(EU)

View Details Get Enquiry
Insulin (Iv)

Strength: 100 units/mL (U-100) in 10 mL vials

Form: Intravenous (IV) solution

Reference Brands: Humulin® R, Novolin® R(US); Actrapid®, Humulin® R, Insuman® Rapid(EU)

View Details Get Enquiry
Flumazenil

Strength: 0.1 mg/mL in 5 mL or 10 mL vials

Form: Intravenous (IV) injection

Reference Brands: Romazicon®(US), Anexate®(EU)

View Details Get Enquiry
Naloxone

Strength: 0.4 mg/mL in 1 mL/10 mL vials, 1 mg/mL in 2 mL prefilled syringes

Form: Intravenous (IV) injection/IM/SQ

Reference Brands: Narcan® (US); Narcan® (EU)

View Details Get Enquiry

Subscribe to Our Newsletter

Stay updated on pharma trends and marketplace opportunities.

We use cookies to ensure you get the best experience. Learn more